|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,902 CHF | +0.62% |
|
-2.57% | +12.00% |
| Apr. 18 | UBS Raises Givaudan to Neutral from Sell, Raises PT | MT |
| Apr. 18 | GIVAUDAN : UBS raises its recommendation | CF |
Givaudan SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CHF 6,684 million compared to CHF 6,322 million a year ago. Net income was CHF 821 million compared to CHF 743 million a year ago.
Basic earnings per share from continuing operations was CHF 89.03 compared to CHF 80.59 a year ago. Diluted earnings per share from continuing operations was CHF 88.37 compared to CHF 79.96 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.00% | 39.23B | |
| +10.52% | 62.69B | |
| -4.60% | 45.57B | |
| +18.26% | 26.87B | |
| +1.32% | 17.72B | |
| +3.97% | 15.27B | |
| -27.99% | 13.94B | |
| -22.62% | 13.44B | |
| -23.93% | 13.15B | |
| +31.00% | 12.9B |
GIVAUDAN SA 
